Xtandi 40 mg soft capsules

DRUG2 trials

Sponsors

Bristol-Myers Squibb Services Unlimited Company, Pfizer Inc.

Conditions

Metastatic Castration-sensitive Prostate CancerPan tumor

Phase 2

Pan Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS sponsored Trials Investigating Nivolumab and Other Cancer Therapies

RecruitingCTIS2023-506914-32-00

Bristol-Myers Squibb Services Unlimited CompanyPan tumor

Start: 2020-05-05Target: 307Updated: 2026-01-19

Phase 3

C3441052 - TALAPRO-3: A Phase 3, Randomized, Double-Blind Study of Talazoparib with Enzalutamide Versus Placebo with Enzalutamide in Men with DDR Gene Mutated Metastatic Castration-Sensitive Prostate Cancer

Active, not recruitingCTIS2024-510809-28-00

Pfizer Inc.Metastatic Castration-sensitive Prostate Cancer

Start: 2021-09-27Target: 207Updated: 2025-12-19